Transcell Oncologics Profile
Key Indicators
- Authorised Capital ₹ 0.15 M
- Paid Up Capital ₹ 0.13 M
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.70 M
- Revenue Growth -29.63%
- Profit Growth 9.71%
- Ebitda 39.03%
- Net Worth -30.08%
- Total Assets -12.49%
About Transcell Oncologics
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999TG2017PTC118680
- Company No.
118680
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Aug 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Transcell Oncologics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uday Chatterjee  | Director | 05-Jul-2021 | Current |
| Vinayender Tulla | Director | 02-Aug-2017 | Current |
| Subhadra Dravida | Director | 02-Aug-2017 | Current |
Financial Performance of Transcell Oncologics.
Transcell Oncologics Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 29.63% decrease. The company also saw a slight improvement in profitability, with a 9.71% increase in profit. The company's net worth observed a substantial decline by a decrease of 30.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Transcell Oncologics?
In 2021, Transcell Oncologics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sri Venkateshwara Multiplexes Private LimitedVinayender Tulla is a mutual person
Canter Technologies Private LimitedVinayender Tulla is a mutual person
Transcell Biosciences Private LimitedUday Chatterjee and Subhadra Dravida are mutual person
Ahammune Biosciences Private LimitedUday Chatterjee is a mutual person
Gostops Hospitality Private LimitedUday Chatterjee is a mutual person
C.T.I. Travels Private LimitedUday Chatterjee is a mutual person
Charges (Loans)
₹0
₹2.70 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.27 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jul 2021 | Hdfc Bank Limited | ₹2.70 M | Satisfied |
How Many Employees Work at Transcell Oncologics?
Unlock and access historical data on people associated with Transcell Oncologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Transcell Oncologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Transcell Oncologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.